A Trial to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME) (GLEAM)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04611152 |
|
Recruitment Status :
Terminated
(Study did not meet primary endpoint)
First Posted : November 2, 2020
Last Update Posted : October 2, 2023
|
Sponsor:
Kodiak Sciences Inc
Information provided by (Responsible Party):
Kodiak Sciences Inc
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | May 11, 2023 |
| Actual Study Completion Date : | August 31, 2023 |